The Addition of Bevacizumab to Oxaliplatin-Based Chemotherapy: Impact Upon Hepatic Sinusoidal Injury and Thrombocytopenia.

Overview of attention for article published in JNCI: Journal of the National Cancer Institute, January 2018

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 29 Dimensions

Readers on

mendeley: 38 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 29 publications that cite this research output.

29

The most recent citing publications are shown below. View all 29 publications that cite this research output on Dimensions.

Chapter 5 Major hepatectomy after preoperative liver regeneration—Experience in MDACC

Book chapter (January 2024)

A contrast-enhanced CT-based whole-spleen radiomics signature for early prediction of oxaliplatin-related thrombocytopenia in patients with gastrointestinal malignancies: a retrospective study

Article in PeerJ (October 2023)

Prior treatment with oxaliplatin-containing regimens and higher total bilirubin levels are risk factors for neutropenia and febrile neutropenia in patients with gastric or esophagogastric junction cancer receiving weekly paclitaxel and ramucirumab therapy: a single center retrospective study

Article in BMC Cancer (October 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.